1. Valentine Y, Nikolajczyk BS. T cells in obesity‐associated inflammation: The devil is in the details. Immunological Reviews.2024;324(1):25-41. [
DOI:10.1111/imr.13354]
2. Artemniak-Wojtowicz D, Kucharska A, Pyrżak B. Obesity and chronic inflammation crosslinking. Central European Journal of Immunology. 2020 ;45(4):461-8. [
DOI:10.5114/ceji.2020.103418]
3. Tran DB, Le NK, Duong MT, Yuna K, Pham LT, Nguyen QT, et al. Drosophila models of the anti‐inflammatory and anti‐obesity mechanisms of kombucha tea produced by Camellia sinensis leaf fermentation. Food Science & Nutrition.2024;12(8):5722-5733. [
DOI:10.1002/fsn3.4223]
4. Ruck L, Wiegand S, Kühnen P. Relevance and consequence of chronic inflammation for obesity development. Molecular and Cellular Pediatrics. 2023;10(1):16. [
DOI:10.1186/s40348-023-00170-6]
5. Liu ZZ, Liu LY, Zhu LY, Zhu J, Luo JY, Wang YF, et al. Plexin B3 guides axons to cross the midline in vivo. Frontiers in Cellular Neuroscience. 2024;18:1292969. [
DOI:10.3389/fncel.2024.1292969]
6. Šamadan L, Papić N, Mijić M, Knežević Štromar I, Gašparov S, Vince A. Do semaphorins play a role in development of fibrosis in patients with nonalcoholic fatty liver disease?. Biomedicines. 2022;10(12):3014. [
DOI:10.3390/biomedicines10123014]
7. Khalafi M, Symonds ME. The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis. Scandinavian journal of medicine & science in sports. 2020;30(11):2020-36. [
DOI:10.1111/sms.13754]
8. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. Jama. 1994;272(2):122-4. [
DOI:10.1001/jama.1994.03520020048013]
9. She J, Nakamura H, Makino K, Ohyama Y, Hashimoto H. Selection of suitable maximum-heart-rate formulas for use with Karvonen formula to calculate exercise intensity. International journal of automation and computing. 2015;12:62-9. [
DOI:10.1007/s11633-014-0824-3]